Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substance

Journal of Steroid Biochemistry and Molecular Biology

Volumn 92, Issue 3, 2004, Pages 199-208

  Trbovich, Alexander M ^a   Martinelle, Nina ^a,b   O'Neill, Francis H ^a   Pearson, Elliot J ^a   Donahoe, Patricia K ^a   Sluss, Patrick M ^a   Teixeira, Jose ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

5 Reductase; Cyp17; Leydig cells; M llerian inhibiting substance

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; EPIANDROSTERONE; PROGESTERONE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; LEYDIG CELL; MICROSOME; MOUSE; MUELLERIAN DUCT; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

17-ALPHA-HYDROXYPROGESTERONE; ANDROSTENEDIONE; ANIMALS; CYCLIC AMP; GLYCOPROTEINS; LEYDIG CELLS; MALE; MICE; MICROSOMES; PROGESTERONE; RATS; STEROID 17-ALPHA-HYDROXYLASE; STEROIDS; TESTICULAR HORMONES;

EID: 8844261189     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.07.002     Document Type: Article

References (43)

1. N. Josso, R.L. Cate, J.Y. Picard, B. Vigier, C.N. di, C. Wilson, S. Imbeaud, R.B. Pepinsky, D. Guerrier, L. Boussin, L. Legeai, and D. Carre-Eusebe Anti-Müllerian hormone: the Jost factor Recent Prog. Horm. Res. 48 1993 1 59
2. J. Teixeira, S. Maheswaran, and P.K. Donahoe Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications Endocr. Rev. 22 5 2001 657 674
3. M.J. Gruijters, J.A. Visser, A.L. Durlinger, and A.P. Themmen Anti-Mullerian hormone and its role in ovarian function Mol. Cell. Endocrinol. 211 1-2 2003 85 90
4. J. Teixeira, E. Fynn-Thompson, A.H. Payne, and P.K. Donahoe Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level Endocrinology 140 10 1999 4732 4738
5. A.M. Trbovich, P.M. Sluss, V.M. Laurich, F.H. O'Neill, D.T. MacLaughlin, P.K. Donahoe, and J. Teixeira Müllerian inhibiting substance lowers testosterone in luteinizing hormone-stimulated rodents Proc. Natl. Acad. Sci. U.S.A. 98 6 2001 3393 3397
6. V.M. Laurich, A.M. Trbovich, F.H. O'Neill, C.P. Houk, P.M. Sluss, A.H. Payne, P.K. Donahoe, and J. Teixeira Mullerian inhibiting substance blocks the protein kinase a-induced expression of cytochrome P450 17{alpha}-hydroxylase/ c17-20 lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation Endocrinology 143 9 2002 3351 3360
7. A.L. Durlinger, P. Kramer, B. Karels, F.H. de Jong, J.T. Uilenbroek, J.A. Grootegoed, and A.P. Themmen Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary Endocrinology 140 12 1999 5789 5796
8. A.L. Durlinger, M.J. Gruijters, P. Kramer, B. Karels, H.A. Ingraham, M.W. Nachtigal, J.T. Uilenbroek, J.A. Grootegoed, and A.P. Themmen Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary Endocrinology 143 3 2002 1076 1084
9. P.T. Masiakos, D.T. MacLaughlin, S. Maheswaran, J. Teixeira, A.F. Fuller Jr., P.C. Shah, D.J. Kehas, M.K. Kenneally, D.M. Dombkowski, T.U. Ha, F.I. Preffer, and P.K. Donahoe Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS Clin. Cancer Res. 5 11 1999 3488 3499
10. D.L. Segev, T.U. Ha, T.T. Tran, M. Kenneally, P. Harkin, M. Jung, D.T. MacLaughlin, P.K. Donahoe, and S. Maheswaran Müllerian-inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway J. Biol. Chem. 275 37 2000 28371 28379
11. D.L. Segev, Y. Hoshiya, M. Hoshiya, T.T. Tran, J.L. Carey, A.E. Stephen, D.T. MacLaughlin, P.K. Donahoe, and S. Maheswaran Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo Proc. Natl. Acad. Sci. U.S.A. 99 1 2002 239 244
12. Y. Ikeda, A. Nagai, M.A. Ikeda, and S. Hayashi Increased expression of Mullerian-inhibiting substance correlates with inhibition of follicular growth in the developing ovary of rats treated with E2 benzoate Endocrinology 143 1 2002 304 312
13. G. Chen, T. Shinka, K. Kinoshita, H.T. Yan, T. Iwamoto, and Y. Nakahori Roles of estrogen receptor alpha (ER alpha) in the regulation of the human Mullerian inhibitory substance (MIS) promoter J. Med. Invest. 50 3-4 2003 192 198
14. A. Nagai, Y. Ikeda, T. Aso, K. Eto, and M.A. Ikeda Exposure of neonatal rats to diethylstilbestrol affects the expression of genes involved in ovarian differentiation J. Med. Dent. Sci. 50 1 2003 35 40
15. Y. Mishina, R. Rey, M.J. Finegold, M.M. Matzuk, N. Josso, R.L. Cate, and R.R. Behringer Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation Genes Dev. 10 20 1996 2577 2587
16. R.R. Behringer, R.L. Cate, G.J. Froelick, R.D. Palmiter, and R.L. Brinster Abnormal sexual development in transgenic mice chronically expressing mullerian inhibiting substance Nature 345 6271 1990 167 170
17. L. Lyet, F. Louis, M.G. Forest, N. Josso, R.R. Behringer, and B. Vigier Ontogeny of reproductive abnormalities induced by deregulation of anti-müllerian hormone expression in transgenic mice Biol. Reprod. 52 2 1995 444 454
18. V. Rouiller-Fabre, S. Carmona, R.A. Merhi, R. Cate, R. Habert, and B. Vigier Effect of anti-Müllerian hormone on Sertoli and Leydig cell functions in fetal and immature rats Endocrinology 139 3 1998 1213 1220
19. C. Racine, R. Rey, M.G. Forest, F. Louis, A. Ferre, I. Huhtaniemi, N. Josso, and N. di Clemente Receptors for anti-Müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation Proc. Natl. Acad. Sci. U.S.A. 95 2 1998 594 599
20. M. Ascoli Regulation of gonadotropin receptors and gonadotropin responses in a clonal strain of Leydig tumor cells by epidermal growth factor J. Biol. Chem. 256 1 1981 179 183
21. F.F. Rommerts, S.R. King, and P.N. Span Implications of progesterone metabolism in MA-10 cells for accurate measurement of the rate of steroidogenesis Endocrinology 142 12 2001 5236 5242
22. A.H. Payne, and G.L. Youngblood Regulation of expression of steroidogenic enzymes in Leydig cells Biol. Reprod. 52 2 1995 217 225
23. D.W. Russell, and J.D. Wilson Steroid 5 alpha-reductase: two genes/two enzymes Annu. Rev. Biochem. 63 1994 25 61
24. M.S. Mahendroo, K.M. Cala, D.P. Landrum, and D.W. Russell Fatal death in mice lacking 5alpha-reductase type 1 caused by estrogen excess Mol. Endocrinol. 11 7 1997 917 927
25. H.K. Lorenzo, J. Teixeira, N. Pahlavan, V.M. Laurich, P.K. Donahoe, and D.T. MacLaughlin New approaches for high-yield purification of Mullerian inhibiting substance improve its bioactivity J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 766 1 2002 89 98
26. M.M. Bradford, and A. Rapid Sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
27. D. Lin, L.H. Zhang, E. Chiao, and W.L. Miller Modeling and mutagenesis of the active site of human P450c17 Mol. Endocrinol. 8 3 1994 392 402
28. T. Yamazaki, T. Ohno, T. Sakaki, M. Akiyoshi-Shibata, Y. Yabusaki, T. Imai, and S. Kominami Kinetic analysis of successive reactions catalyzed by bovine cytochrome p450(17alpha,lyase) Biochemistry 37 9 1998 2800 2806
29. H. Tagashira, S. Kominami, and S. Takemori Kinetic studies of cytochrome P-45017 alpha, lyase dependent androstenedione formation from progesterone Biochemistry 34 34 1995 10939 10945
30. P.J. O'Shaughnessy, L. Willerton, and P.J. Baker Changes in Leydig cell gene expression during development in the mouse Biol. Reprod. 66 4 2002 966 975
31. J.M. Saez Leydig cells: endocrine, paracrine, and autocrine regulation Endocr. Rev. 15 5 1994 574 626
32. W.L. Miller Androgen biosynthesis from cholesterol to DHEA Mol. Cell. Endocrinol. 198 1-2 2002 7 14
33. J. Li, Y. Li, C. Son, and A.M. Brodie Inhibition of androgen synthesis by 22-hydroximino-23,24-bisnor-4-cholen-3-one Prostate 26 3 1995 140 150
34. S. Andersson, and D.W. Russell Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases Proc. Natl. Acad. Sci. U.S.A. 87 10 1990 3640 3644
35. J.D. Wilson, R.J. Auchus, M.W. Leihy, O.L. Guryev, R.W. Estabrook, S.M. Osborn, G. Shaw, and M.B. Renfree 5Alpha-androstane-3alpha,17beta-diol is formed in Tammar Wallaby pouch young testes by a pathway involving 5alpha-pregnane-3alpha,17alpha-diol-20-one as a key intermediate Endocrinology 144 2 2003 575 580
36. M.S. Mahendroo, K.M. Cala, and D.W. Russell 5Alpha-reduced androgens play a key role in murine parturition Mol. Endocrinol. 10 4 1996 380 392
37. C.M. Telleria, C.O. Stocco, A.O. Stati, and R.P. Deis Progesterone receptor is not required for progesterone action in the rat corpus luteum of pregnancy Steroids 64 11 1999 760 766
38. G. Puia, J.M. Mienville, K. Matsumoto, H. Takahata, H. Watanabe, E. Costa, and A. Guidotti On the putative physiological role of allopregnanolone on GABA(A) receptor function Neuropharmacology 44 1 2003 49 55
39. M.D. Wang, T. Backstrom, and S. Landgren The inhibitory effects of allopregnanolone and pregnanolone on the population spike, evoked in the rat hippocampal CA1 stratum pyramidale in vitro, can be blocked selectively by epiallopregnanolone Acta Physiol. Scand. 169 4 2000 333 341
40. L.H. Zhang, H. Rodriguez, S. Ohno, and W.L. Miller Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome Proc. Natl. Acad. Sci. U.S.A. 92 23 1995 10619 10623
41. A.V. Pandey, S.H. Mellon, and W.L. Miller Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17 J. Biol. Chem. 278 5 2003 2837 2844
42. R.J. Auchus, T.C. Lee, and W.L. Miller Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer J. Biol. Chem. 273 6 1998 3158 3165
43. R.R. Behringer, M.J. Finegold, and R.L. Cate Mullerian-inhibiting substance function during mammalian sexual development Cell 79 3 1994 415 425